Developing novel drugs for gastric cancer (GC) is greatly needed, and a reactive oxygen
species (ROS)-modulating strategy has been demonstrated to be useful for cancer …

Elastin (ELN) fibers are essential constituents of the tumor microenvironment of gastric
cancer (GC). However, few studies have investigated the clinical prognostic significance of …

Gastric cancer (GC) is one of the most lethal malignancies worldwide. However, the
molecular mechanisms underlying gastric carcinogenesis remain largely unknown. Over the …

Gastric cancer has developed as a very common gastrointestinal tumors, with recent
effective advancements in the diagnosis and treatment of early gastric cancer. However, the …

Background Early gastric cancer (EGC) is invasive gastric cancer that invades no deeper
than the submucosa, regardless of lymph node metastasis (LNM). It is mainly treated by …

Gastric cancer (GC) remains a predominant form of malignant tumor globally, necessitating
innovative non-surgical therapeutic approaches. This investigation aimed to delineate the …

MATTERHORN study design: Patients diagnosed with histologically confirmed, Stage II or
higher, resectable GC/GEJC not previously Page 1 wcgic2021 Presented at …

Gastrointestinal cancer (GIC) has high morbidity and mortality as one of the main causes of
cancer death. Preoperative risk stratification is critical to guide patient management, but …

Cancer has currently become a serious public health issue in many countries worldwide,
and tumors of the digestive system have attracted an increasing number of researchers' due …

Multidrug resistance (MDR) is a major obstacle to chemotherapy, which leads to ineffective
chemotherapy, an important treatment strategy for gastric cancer (GC). The abnormality of …